Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours

Annals of Oncology

Volumn 24, Issue 1, 2013, Pages 84-90

  Miyanaga, A ^a,b   Honda, K ^a   Tsuta, K ^c   Masuda, M ^a   Yamaguchi, U ^a   Fujii, G ^a   Miyamoto, A ^d   Shinagawa, S ^d   Miura, N ^a   Tsuda, H ^c   Sakuma, T ^e   Asamura, H ^c   Gemma, A ^b   Yamada, T ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d Trans Genic Inc   (Japan)

^e Mitsui Knowledge Industry Co   (Japan)

Author keywords

Actinin 4; Alternative splice variant; Diagnostic marker; High grade neuroendocrine tumour; Prognosis; Pulmonary neoplasm

Indexed keywords

ALPHA ACTININ 4; ALPHA ACTININ 4 UB; ALPHA ACTININ 4 VA; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 13G9; MONOCLONAL ANTIBODY 15H2; UNCLASSIFIED DRUG;

ACTN4 GENE; ADULT; AGED; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HIGH GRADE NEUROENDOCRINE PULMONARY TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NEUROENDOCRINE TUMOR; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84871565885     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds215     Document Type: Article

References (27)

1. Travis WD, Linnoila RI, Tsokos MG et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991; 15: 529-553.
2. Travis WD, Colby TV, Corrin B et al. World Health Organization International Histological Classification of Tumors. Histological Typing of Lung and Pleural Tumors, 3rd edition. Berlin: Springer 1999.
3. Cooper WA, Thourani VH, Gal AA et al. The surgical spectrum of pulmonary neuroendocrine neoplasms. Chest 2001; 119: 14-18.
4. Travis WD, Rush W, Flieder DB et al Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998; 22: 934-944.
5. Asamura H, Kameya T, Matsuno Y et al Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006; 24: 70-76.
6. Travis WD Advances in neuroendocrine lung tumors. Ann Oncol 2010; 21(Suppl 7): vii65-vii71.
7. Takei H, Asamura H, Maeshima A et al Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 2002; 124: 285-292.
8. Ionescu DN, Treaba D, Gilks CB et al Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance. Am J Surg Pathol 2007; 31: 26-32.
9. Honda K, Yamada T, Endo R et al Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 1998; 140: 1383-1393.
10. Honda K, Yamada T, Seike M et al Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene 2004; 23: 5257-5262.
11. Pio R, Montuenga LM Alternative splicing in lung cancer. J Thorac Oncol 2009; 4: 674-678.
12. Sakaguchi N, Kimura T, Matsushita S et al Generation of high-affinity antibody against T-cell-dependent antigen in the Ganp gene-transgenic mouse. J Immunol 2005; 174: 4485-4494.
13. Ono M, Matsubara J, Honda K et al Prolyl 4-hydroxylation of alpha-fibrinogen: a novel protein modification revealed by plasma proteomics. J Biol Chem 2009; 284: 29041-29049.
14. Matsubara J, Ono M, Negishi A et al Identification of a predictive biomarker for hematologic toxicities of gemcitabine. J Clin Oncol 2009; 27: 2261-2268.
15. Satow R, Shitashige M, Jigami T et al β-Catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells. Gastroenterology 2012; 142: 572-581.
16. Travis WD, Brambilla E, Muller-Hermelink HK World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press 2004.
17. Sobin L, Gospodarowicz M, Wittrkind C. TNM Classification of Malignant Tumors. New York: Wiley-Blackwell 2010.
18. Kikuchi S, Honda K, Tsuda H et al. Expression and gene amplification of actinin- 4 in invasive ductal carcinoma of the pancreas. Clin Cancer Res 2008; 14: 5348-5356.
19. Yamamoto S, Tsuda H, Honda K et al Actinin-4 expression in ovarian cancer: a novel prognostic indicator independent of clinical stage and histological type. Mod Pathol 2007; 20: 1278-1285.
20. Idogawa M, Yamada T, Honda K et al Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex. Gastroenterology 2005; 128: 1919-1936.
21. Yamaguchi U, Nakayama R, Honda K et al Distinct gene expression-defined classes of gastrointestinal stromal tumor. J Clin Oncol 2008; 26: 4100-4108.
22. Honda K, Yamada T, Hayashida Y et al Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 2005; 128: 51-62.
23. Yamagata N, Shyr Y, Yanagisawa K et al A training-testing approach to the molecular classification of resected non-small cell lung cancer. Clin Cancer Res 2003; 9: 4695-4704.
24. Kaplan JM, Kim SH, North KN et al Mutations in ACTN4, encoding alphaactinin- 4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24: 251-256.
25. Usuda J, Ichinose S, Ishizumi T et al Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung. Lung Cancer 2011; 72: 355-359.
26. Usuda J, Ichinose S, Ishizumi T et al Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery. Lung Cancer 2011; 74: 332-337.
27. Casali C, Stefani A, Rossi G et al The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 2004; 77: 247-252.